A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC
- Status
- COMPLETED
- Phase
- PHASE3
Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib
- Status
- UNKNOWN
- Phase
- PHASE2
MRI of the Liver With Eovist
- Status
- TERMINATED
- Phase
- N/A
Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT
- Status
- COMPLETED
- Phase
- N/A
Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
ABT-888 and Temozolomide for Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE4
Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- N/A
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Carbon Ion Radiotherapy for Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- NA
Stereotaxic Irradiation of Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib
- Status
- COMPLETED
- Phase
- PHASE3
Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids
- Status
- COMPLETED
- Phase
- NA
Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE3
Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1